TickerFactsScreenerDevelopers

Adaptimmune Therapeutics PLC (ADAPY) — Net Income

Annual figures by fiscal year, from SEC filings.

2014: -$11.60M2015: -$22.06M2016: -$71.58M2017: -$70.14M2018: -$95.51M2019: -$137.16M2020: -$130.09M2021: -$158.09M2022: -$165.46M2023: -$113.87M2024: -$70.81M-$70.81M
2014Net Income (USD)2024
Fiscal YearNet IncomeChange YoY
2024-$70.81M+37.8%
2023-$113.87M+31.2%
2022-$165.46M-4.7%
2021-$158.09M-21.5%
2020-$130.09M+5.2%
2019-$137.16M-43.6%
2018-$95.51M-36.2%
2017-$70.14M+2.0%
2016-$71.58M-224.5%
2015-$22.06M-90.1%
2014-$11.60M—